Neogen Chemicals Limited has made a disclosure to BSE Limited and National Stock Exchange of India Limited pursuant to Regulation 7(2) of the SEBI (Prohibition of Insider Trading) Regulations, 2015.

The disclosure concerns Mrs. Heena Hitesh Reshamwala, who is the Immediate Relative (Spouse) of Mr. Hitesh Bharatkumar Reshamwala, Director of Neogen Ionics Limited. Neogen Ionics Limited is a wholly owned subsidiary of Neogen Chemicals Limited.

Mrs. Heena Hitesh Reshamwala sold 900 equity shares of Neogen Chemicals Limited on November 17, 2026, through a market transaction on the National Stock Exchange (NSE).

Transaction Details:

  • Date of Transaction: November 17, 2026
  • Number of Securities Sold: 900 equity shares
  • Percentage of Paid-up Capital: 0.003%
  • Mode of Transaction: Sale through stock exchange (on-market)
  • Consideration Value: ₹24,42,654
  • DP ID/Client ID: IN300513-89656143
  • Exchange: NSE

Holding Details:

  • Securities Held Prior to Transaction: 5,819 equity shares (approximately 0.02% of the share capital of the Company)
  • Securities Held Post Transaction: 4,919 equity shares (approximately 0.02% of the share capital of the Company)

The disclosure was received by the Company from Mrs. Heena Hitesh Reshamwala within the prescribed timeline and was submitted to the exchanges on November 18, 2026. The disclosure includes the required Form C as per SEBI PIT Regulations.

The document was signed and submitted by Unnati Rajesh Kanani, Company Secretary and Compliance Officer of Neogen Chemicals Limited (Membership No. A35131).